They are not intended to represent clinical evidence in humans, and BPC-157 has not been approved by the FDA, EMA, or any other regulatory authority for any indication
In clinical studies, 400mg taken daily with diet and exercise supported meaningful reductions in BMI, waist, and hip measurements after just four weeks
Gene-Expression & Cellular-Maintenance Research Research involving GHK-Cu has investigated its interaction with: Cellular-repair and maintenance pathways Stem-cellrelated signaling mechanisms Antioxidant-defense pathways Tissue-remodeling signaling Fibrosis-related pathways Chronic inflammationrelated mechanisms Research interest commonly explores how GHK-Cu may influence broader regenerative and physiological-resilience pathways associated with healthy-aging and tissue-maintenance research
MDA-MB-231 (female, ATCC Cat# HTB-26), MCF-7 (female, ATCC Cat# HTB-22), HeLa (female, ATCC Cat# CCL-2), A549 (male, ATCC Cat# CCL-185)